C12N 2760/12222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/12222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 10 US grants and 22 published applications in this corpus.
Search patents in C12N- Granted patents
- 10
- Published applications
- 22
- Assignees
- 18
- Inventors
- 57
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 3 |
| 2022 | 0 | 0 |
| 2023 | 2 | 3 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Attenuated variant of the rift valley fever virus, composition comprising same, and uses thereof24 Mar 2026US 12,584,116 B2Consejo Superior De Investigaciones Cientificas (Csic)
- Bunyavirales vaccine26 Aug 2025US 12,397,048 B2CureVac AG
- Rift valley fever vaccine9 May 2023US 11,643,640 B2Board of Regents, The University of Texas System
- Bunyavirales vaccine14 Mar 2023US 11,602,557 B2Cure Vac SE
- Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses30 Mar 2021US 10,961,279 B2ISD Immunotech ApS
- Bunyavirales vaccine2 Apr 2026US 2026/0091101 A1CureVac AG
- Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses9 May 2024US 2024/0150409 A1ISD Immunotech ApS
- Bovine herpesvirus type 1 (bohv-1) quadruple gene deleted mutant14 Mar 2024US 2024/0084325 A1The Boards of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Bunyavirales vaccine21 Dec 2023US 2023/0405107 A1CureVac AG
- Modified filamentous fungi for production of exogenous proteins5 Oct 2023US 2023/0313121 A1Dyadic International (USA), Inc.
Most cited
By later US patents
- Bunyavirales vaccine9US 11,602,557 B2Cure Vac SE · 2023
- Vaccines against rift valley fever virus5US 4,735,800 AMolecular Genetics, Inc. · 1988
- Reverse genetic system for rift valley fever virus and uses thereof5US 8,084,248 B2Board of Regents, The University of Texas System · 2011
- Exosomes and methods of making and using the same3US 10,590,171 B2Board of Regents, The University of Texas System · 2020
- Pathogenic phlebovirus isolates and compositions and methods of use1US 9,421,250 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016